Biocon Ties up with Mylan for Insulin Marketing
7
Global pharmaceutical major Mylan has entered into an agreement with Bangalore-based Biocon for the global development and commercialization of the latter’s generic insulin analog products (long lasting insulins), which has a global addressable mark
